Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

MH701 Psychopharmacology > Antidepressants > Flashcards

Antidepressants Flashcards

1
Q

Factors favoring treatment with an antidepressant: (response can be expected in 50-75% of pts.)

A
  1. Agitation
  2. Problems with sleep and/or appetite
  3. history of response to antidepressant, patient preference and moderate to severe symptoms.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Choice of Antidepressant

A
  1. Antidepressant response history (if not initial episode)
  2. Comorbidities
  3. Depressive symptoms
  4. Safety/tolerability (MAOIs and TCA’s are not appropriate first-line agents due to side effects and food, drug interactions with MAOIs)
  5. Drug interactions
  6. Pharmacokinetics
  7. Cost
  8. Patient preference
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

For most patients, the initial therapy will be with

A

a SSRI, SNRI, bupropion (Wellbutrin) if no anxiety component of depression, a dopamine-reuptake inhibitor or mirtazapine (Remeron) an alpha-2 antagonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Depression with pain consider

A

SNRI orTCA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Depression w nicotine addiction

A

Bupropion (Wellbutrin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Depression with loss of appetite, weight loss and/or insomnia

A

Mirtazapine (Remeron)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Mirtazapine (Remeron)

A

Increases appetite
Somnolence may be an issue at lower doses but not at higher doses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

SSRIs from most energizing (activating) to the most sedating

A

Fluoxetine (Prozac),
Sertraline (Zoloft),
Citalopram (Celexa),
Escitalopram (Lexapro),
Paroxetine (Paxil).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

When treating depression w/ anxiety:

A
  • Use a less energizing SSRI, Venlafaxine or Duloxetine.
  • Consider Viibryd if others fail.
  • If you use Fluoxetine in a patient w/ anxiety be sure to start low and titrate slowly to avoid activation of anxiety
  • Avoid Wellbutrin as this is too activating and can cause increased anxiety.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Most common clinical mistake leading to an unsuccessful trial of an antidepressant drug is

A

the use of too low a dosage for too short a time. Unless adverse events prevent it, the dosage of an antidepressant should be raised to the maximum recommended level and maintained at that level for at least 4 or 5 weeks before a drug trial is considered unsuccessful

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Side Effects (in general)

A
  • Take advantage of the side effects of a medication such as utilizing utilize a sedating antidepressant in a patient with insomnia.
  • For undesirable side effects, the provider can lower the dose or switch to an agent with a different side effect profile.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

To reduce side effects of Sexual Dysfunction

A
  • For a reduction in sexual side effects which are common with SSRIs, SNRIs, and TCAs, bupropion is recommended.
  • If the antidepressant is working well and you do not want to switch to bupropion, this can be added to an SSRI. - Other add-ons include buspirone or a phosphodiesterase inhibitor.
  • Sildenafil does reduce and tadalafil may reduce SSRI-induced sexual dysfunction in men, whereas bupropion may be effective in both men and women.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

GI Side Effects

A

Nausea and vomiting are not uncommon with SSRIs and SNRIs; especially fluoxetine (Prozac), venlafaxine(Effexor) and duloxetine (Cymbalta). These side effects typically decrease with continued treatment. Diarrhea may be a persistent problem with sertraline (Zoloft). To decrease nausea have the patient take the medication with food or divide doses.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Activation, agitation, restlessness, insomnia and anxiety may occur with

A

SSRIs, SNRIs and buproprion. These side effects may be reduced over time.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

can cause akathisia (inner restlessness)

A

SSRIs and SNRIs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Insomnia may be reduced through

A

a.m. dosing, good sleep hygiene, CBT, melatonin or adding trazodone, a serotonin reuptake inhibitor/antagonist.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Sedation is most common with

A

TCA’s, mirtazapine at low doses and nefazodone. Paroxetine (Paxil) tends to be the most sedating of the SSRIs and is a good choice for a patient with depression and overlying anxiety.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

a good choice for patients with fatigue or sleepiness

A

Buproprion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Diarrhea may be a persistent problem with

A

sertraline (Zoloft).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Nausea and vomiting are not uncommon with

A

SSRIs and SNRIs; especially fluoxetine (Prozac), venlafaxine(Effexor), and duloxetine (Cymbalta)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Reduces sexual dysfunction in men

A

Sildenafil does reduce and tadalafil may reduce SSRI-induced and bupropion may be effective

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Reduces sexual dysfunction in women

A

bupropion may be effective

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Weight Gain

A
  • The most common SSRI to cause weight gain is paroxetine (Paxil)
  • TCAs often cause weight gain
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Are weight neutral or may cause a modest weight loss.

A

Bupropion (Wellbutrin) and fluoxetine (Prozac)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

May cause weight loss

A

Venlafaxine (Effexor)

26
Q

Discontinuation Syndrome if not Tapered

A
  • Paroxetine (Paxil) is the most common SSRI with venlafaxine (Effexor) being the next most likely to cause this syndrome with abrupt discontinuation.
  • Fluoxetine (Prozac) is least likely.
27
Q

S/Sx of Discontinuation Syndrome

A

typically flu-like or neurologic.

28
Q

For patients with compliance issues

A

an SSRI such as Fluoxetine (Prozac) is likely a good choice to avoid recurrent discontinuation syndrome symptoms.

29
Q

Anticholinergic Side Effects

A
  • TCAs can cause anticholinergic symptoms of mental status changes, urinary retention, and blurred vision.
  • Desipramine has the least anticholinergic side effects
  • Amitriptyline has the greatest anticholinergic side effects of TCAs.
  • SNRIs and bupropion can also cause dry mouth and constipation.
30
Q

Arrhythmias and Orthostatic Hypotension

A

TCAs have the potential to cause arrhythmias which are lethal with an overdose. This is why, with a potentially suicidal patient, providing a script for TCAs would be contraindicated.

31
Q

If starting a patient over 50 on a TCA

A

an ECG should be done as well as a cardiovascular risk assessment.

32
Q

FDA recommends against using doses > 40 mg/day of Citalopram (Celexa)

A

due to the possible increased risk of QT interval prolongation and torsade de pointe.

33
Q

Citalopram (Celexa) is associated with

A

potentially fatal abnormal heart rhythms such as QT interval prolongation and torsade de pointe.

34
Q

dose-dependent HTN caused by

A

buproprion (Wellbutrin),
venlafaxine (Effexor),
duloxetine (Cymbalta),
desvenlafaxine (Pristiq)

35
Q

hypertensive crisis may be caused by

A

MAOs combined with SSRIs, SNRIs, and TCAs

36
Q

Serotonin Syndrome is more commonly seen with

A

an SSRI is combined with another drug such as a triptan, tramadol, or linezolid

37
Q

Serotonin Syndrome is most severe when

A

an SSRI is combined with an MAOI

38
Q

Which SSRIs are the most significant enzyme inhibitors are

A

fluoxetine (Prozac), fluvoxamine (Luvox) and paroxetine (Paxil)

39
Q

the greatest potential for inhibition of the metabolism of other drugs among the SNRIs

A

Duloxetine (Cymbalta)

40
Q

Initial improvement

A

may be seen in 1 to 2 weeks but typically the maximum improvement ranges from four to 12 weeks are required.

41
Q

If no response is seen in 4 to 8 weeks with the maximally tolerated dose

A

then options are to switch to a different antidepressant within the same or different class.

42
Q

After complete remission of symptoms, antidepressant therapy should continue for

A

at least four to nine months (you may see up to 12 months in the literature as well).

43
Q

who will most likely need continuous maintenance therapy

A

Individuals who have had three or more episodes of depression most likely will need continuous maintenance therapy. You may see two or more episodes in some of the literature as well.

44
Q

A response is characterized as at least

A

a 50% improvement in symptoms.

45
Q

When treatment of depression results in the removal of essentially all symptoms,

A

is called remission for the first several months (e.g., up to 6 months).

46
Q

Recovery is described as

A

being symptom-free for 6 months or more.

47
Q

a relapse is

A

When depression returns before there is a full remission of symptoms or within the first several months following remission of symptoms,

48
Q

When depression symptoms return after a patient has recovered

A

it is called a recurrence

49
Q

SIGECAPS

A

Sleep disturbances
Interest decreased in pleasure activities and sex
Guilty feelings
Energy decreased
Concentration decreased
Appetite (up or down)
Psychomotor function decreased
Suicidal ideations

50
Q

Specifiers for depressive disorders

A

Anxious
Mixed features (see bipolar)
Melancholic
with Psychosis
Catatonic
Peripartum/postpartum
Seasonal
Atypical

51
Q

The objective of pharmacologic treatment is

A

symptom remission, not just symptom reduction.

52
Q

PHARMACOTHERAPY of antidepressants

A
  • The use of pharmacotherapy approx. doubles the chances that a depressed patient will recover in 1 mos.
  • Efficacy is similar across all antidepressants, Tolerability will vary
  • All current anti-depressants may take up to 3 to 4 weeks to exert significant effects earlier
  • Choice of antidepressants is determined by the side effect profile related patient’s physical status, temperament, and lifestyle.
  • Continued symptoms without full remission—likely to cause relapse or reoccurrence of depressive episodes & impaired functioning
53
Q

CLINICAL GUIDELINES

A
  • The most common clinical mistake leading to an unsuccessful trial of an antidepressant drug is the use of too low a dosage for too short a time*
  • Unless adverse effects prevent it, the dosage of an antidepressant should be raised to the maximum recommended level and maintained at that level for at least 4 or 5 weeks before a drug trial is considered unsuccessful.
  • Alternatively, if a patient is improving clinically on a low dosage of the drug, the dosage should not be raised unless clinical improvement stops before maximal benefit
    obtained.
  • If not responding to appropriate dosages within 2-3 weeks, clinicians can decide whether to test plasma concentrations or rule out noncompliance or unusual
    pharmacokinetic response
  • Assess pharmacokinetics to assess which meds may require a higher or lower dose based on metabolism
54
Q

INITIAL MEDICATION SELECTION

A
  • No difference in overall efficacy, speed of response, or long-term effectiveness
  • Differ in pharmacology, drug-drug interactions, short/long term SE’s, discontinuation symptoms, ease of dose adjustment
  • Start with Selective serotonin reuptake inhibitors (SSRIs)- most commonly prescribed for depression
  • Depends on family history & treatment response, course of illness, chronic illness, symptoms severity, concurrent medical conditions
  • Drug-drug interactions, and patient preference. Earlier
    treatment response predicts future responses
55
Q

DURATION

A

Antidepressant treatment should be maintained for at least 6 mos. or the length of a previous episode, whichever is greater.

56
Q

drug dose should be tapered gradually over

A

1 to 2 weeks, depending on the half-life of the drug

57
Q

MDD with psychosis may require a combo:

A

antidepressant+ atypical antipsychotic

58
Q

ACUTE TREATMENT FAILURES

A
  1. Inability to tolerate side effects even with a positive response to treatment
  2. Development of an adverse side effect
  3. Lack of response from treatment
  4. Incorrect diagnosis
59
Q

TYPES OF ANTIDEPRESSANTS

A

SSRIs
 Fluoxetine, Sertraline, Citalopram, Escitalopram, Paroxetine, Fluvoxamine
 SNRIs
Venlafaxine, Duloxetine, Desvenlafaxine, levomilnacipran
 TCAs
Amitriptyline, Nortriptyline, Imipramine, Doxepin, Desipramine
 Atypicals
(Tetracyclic: Mirtazapine & Trazodone)
 Bupropion (NDRI), Mirtazapine, Trazodone
 MAOIs
Nardil, Parnate, Marplan
 SPARI (SSRI and Serotonin Modulators)
Vilazodone, Votioxetine

60
Q

SEROTONIN SYNDROME - Cause:

A

 Taking more than one serotonin-related medication
(prescription & CAM) - St. John’s Wart, SAMe, concurrent MAOI, Lithium

61
Q

SEROTONIN SYNDROME - Symptoms

A

PROGRESSION
1. diarrhea & cramps,
2. restlessness,
3. extreme agitation;
hyperreflexia (overactive or overresponsive reflexes);
autonomic instability (rapid fluctuations in vitals)
4. Myoclonus (sudden, involuntary jerking of a muscle or group of muscles), Seizures, Hyperthermia, shivering (uncontrollable), rigidity:
5.Delirium, coma, status epilepticus, CV collapse,
Death

Other: Diaphoresis, Tremor, Chills,, Ataxia (loss of full control of bodily movements), Headache, Insomnia

62
Q

SEROTONIN SYNDROME - Treatment

A

DC SSRI;
Muscle Relaxants (Dantrium);
Serotonin Blocking Agents (Periactin-);
O2; IV fluids; Meds to control BP and HR;
A breathing tube and medication to paralyze your muscles

MH701 Psychopharmacology (7 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions